Blood monocytes isolated from MS patients show altered expression of microRNAs (195), microvescicle release (196), cytokines (197), norepinephrine (198), and enhanced CCL2-, CCL5-, and CXCL1-driven migration (188, 199) compared to cells from healthy controls. Here, CCL5 is linked to myeloid sarcoma.